Antibiotic Adjuvant Therapy for Multi-Drug Resistant Carbapenemases Producing Klebsiella pneumoniae Associated Sepsis: A Case Study

Antibiotic Adjuvant Therapy for Multi-Drug Resistant Carbapenemases Producing Klebsiella pneumoniae Associated Sepsis: A Case Study

Rising resistance and spread of K. pneumoniae strains, create great concerns in treating sepsis patients due to high incidence of mortality and morbidity. The current study is a case of a 20-year-old male with sepsis and bilateral lung lesions infected with MultiDrug Resistant (MDR) carbapenemase p...

Full description

Bibliographic Details
Main Author: Robin Gupta
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2016-04-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
elores
enterobacteriaceae
esbl
mbl
Online Access:https://jcdr.net/articles/PDF/7697/17544_CE(Ra1)_F(GH)_PF1(VIAK)__PFA(AK)_PF2(PRO).pdf
id doaj-f7f46787763e485cb9f889317dc17595
record_format Article
spelling doaj-f7f46787763e485cb9f889317dc175952020-11-25T03:11:35ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2016-04-01104DD08DD0910.7860/JCDR/2016/17544.7697Antibiotic Adjuvant Therapy for Multi-Drug Resistant Carbapenemases Producing Klebsiella pneumoniae Associated Sepsis: A Case StudyRobin Gupta0Medical Practitioner, Government Medical College and Hospital, Chandigarh, India.Rising resistance and spread of K. pneumoniae strains, create great concerns in treating sepsis patients due to high incidence of mortality and morbidity. The current study is a case of a 20-year-old male with sepsis and bilateral lung lesions infected with MultiDrug Resistant (MDR) carbapenemase producing K. pneumoniae (KPC) showing resistance to carbapenem and polymyxin. Based on sensitivity report, patient was put on antibiotic adjuvant: Elores (ceftriaxone, sulbactam, disodium edetate) along with fluconazole for 10 days. Elores was instituted with remarkable recovery and patient was discharged. https://jcdr.net/articles/PDF/7697/17544_CE(Ra1)_F(GH)_PF1(VIAK)__PFA(AK)_PF2(PRO).pdfeloresenterobacteriaceaeesblmbl
collection DOAJ
language English
format Article
sources DOAJ
author Robin Gupta
spellingShingle Robin Gupta
Antibiotic Adjuvant Therapy for Multi-Drug Resistant Carbapenemases Producing Klebsiella pneumoniae Associated Sepsis: A Case Study
Journal of Clinical and Diagnostic Research
elores
enterobacteriaceae
esbl
mbl
author_facet Robin Gupta
author_sort Robin Gupta
title Antibiotic Adjuvant Therapy for Multi-Drug Resistant Carbapenemases Producing Klebsiella pneumoniae Associated Sepsis: A Case Study
title_short Antibiotic Adjuvant Therapy for Multi-Drug Resistant Carbapenemases Producing Klebsiella pneumoniae Associated Sepsis: A Case Study
title_full Antibiotic Adjuvant Therapy for Multi-Drug Resistant Carbapenemases Producing Klebsiella pneumoniae Associated Sepsis: A Case Study
title_fullStr Antibiotic Adjuvant Therapy for Multi-Drug Resistant Carbapenemases Producing Klebsiella pneumoniae Associated Sepsis: A Case Study
title_full_unstemmed Antibiotic Adjuvant Therapy for Multi-Drug Resistant Carbapenemases Producing Klebsiella pneumoniae Associated Sepsis: A Case Study
title_sort antibiotic adjuvant therapy for multi-drug resistant carbapenemases producing klebsiella pneumoniae associated sepsis: a case study
publisher JCDR Research and Publications Private Limited
series Journal of Clinical and Diagnostic Research
issn 2249-782X
0973-709X
publishDate 2016-04-01
description Rising resistance and spread of K. pneumoniae strains, create great concerns in treating sepsis patients due to high incidence of mortality and morbidity. The current study is a case of a 20-year-old male with sepsis and bilateral lung lesions infected with MultiDrug Resistant (MDR) carbapenemase producing K. pneumoniae (KPC) showing resistance to carbapenem and polymyxin. Based on sensitivity report, patient was put on antibiotic adjuvant: Elores (ceftriaxone, sulbactam, disodium edetate) along with fluconazole for 10 days. Elores was instituted with remarkable recovery and patient was discharged.
topic elores
enterobacteriaceae
esbl
mbl
url https://jcdr.net/articles/PDF/7697/17544_CE(Ra1)_F(GH)_PF1(VIAK)__PFA(AK)_PF2(PRO).pdf
work_keys_str_mv AT robingupta antibioticadjuvanttherapyformultidrugresistantcarbapenemasesproducingklebsiellapneumoniaeassociatedsepsisacasestudy
_version_ 1724653438684364800

Similar Items